NIH· @NIH · X·· 1 天前AI 评分18
AI 导读
患有高嗜酸性粒细胞综合征(HES)?NIH 正在研究将已获批药物 dupilumab 与其他治疗联合用于成人 HES 患者。 如果您年满 18 岁,并因 HES 正在使用 mepolizumab、reslizumab 或 benralizumab,您可能符合条件。 请致电 NIH CC 患者招募办公室 833-JOIN-NIH。 请提及研究编号 #001979-I 🔗http://go.nih.gov/efFo81U
正文
Have hypereosinophilic syndrome (HES)? The NIH is studying dupilumab, an approved drug, combined with other treatments for adults with HES.
You may be eligible if you are 18+ and take mepolizumab, reslizumab, or benralizumab for HES.
Call the NIH CC Office of Patient Recruitment at 833-JOIN-NIH.
Refer to study #001979-I 🔗http://go.nih.gov/efFo81U
来源:NIH · x.com